Skip to main navigation Skip to search Skip to main content

Deinococcus Mn2+-peptide complex: A novel approach to alphavirus vaccine development

  • Manoshi Gayen
  • , Paridhi Gupta*
  • , Elaine M. Morazzani
  • , Elena K. Gaidamakova
  • , Barbara Knollmann-Ritschel
  • , Michael J. Daly
  • , Pamela J. Glass
  • , Radha K. Maheshwari
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Abstract

Over the last ten years, Chikungunya virus (CHIKV), an Old World alphavirus has caused numerous outbreaks in Asian and European countries and the Americas, making it an emerging pathogen of great global health importance. Venezuelan equine encephalitis virus (VEEV), a New World alphavirus, on the other hand, has been developed as a bioweapon in the past due to its ease of preparation, aerosol dispersion and high lethality in aerosolized form. Currently, there are no FDA approved vaccines against these viruses. In this study, we used a novel approach to develop inactivated vaccines for VEEV and CHIKV by applying gamma-radiation together with a synthetic Mn-decapeptide-phosphate complex (MnDpPi), based on manganous-peptide-orthophosphate antioxidants accumulated in the extremely radiation-resistant bacterium Deinococcus radiodurans. Classical gamma-irradiated vaccine development approaches are limited by immunogenicity-loss due to oxidative damage to the surface proteins at the high doses of radiation required for complete virus-inactivation. However, addition of MnDpPi during irradiation process selectively protects proteins, but not the nucleic acids, from the radiation-induced oxidative damage, as required for safe and efficacious vaccine development. Previously, this approach was used to develop a bacterial vaccine. In the present study, we show that this approach can successfully be applied to protecting mice against viral infections. Irradiation of VEEV and CHIKV in the presence of MnDpPi resulted in substantial epitope preservation even at supra-lethal doses of gamma-rays (50,000 Gy). Irradiated viruses were found to be completely inactivated and safe in vivo (neonatal mice). Upon immunization, VEEV inactivated in the presence of MnDpPi resulted in drastically improved protective efficacy. Thus, the MnDpPi-based gamma-inactivation approach described here can readily be applied to developing vaccines against any pathogen of interest in a fast and cost-effective manner.

Original languageEnglish
Pages (from-to)3672-3681
Number of pages10
JournalVaccine
Volume35
Issue number29
DOIs
StatePublished - 22 Jun 2017

Keywords

  • Aerosol challenge
  • Chikungunya virus
  • Deinococcus radiodurans
  • Inactivated vaccine
  • MnDpPi
  • Venezuelan equine encephalitis virus

Fingerprint

Dive into the research topics of 'Deinococcus Mn2+-peptide complex: A novel approach to alphavirus vaccine development'. Together they form a unique fingerprint.

Cite this